Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImageneBio (IMA) Liabilities and Shareholders Equity (2020 - 2024)

Historic Liabilities and Shareholders Equity for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $149.0 million.

  • ImageneBio's Liabilities and Shareholders Equity fell 3081.11% to $149.0 million in Q3 2024 from the same period last year, while for Dec 2024 it was $479.3 million, marking a year-over-year decrease of 3449.15%. This contributed to the annual value of $192.1 million for FY2023, which is 1151.35% up from last year.
  • As of Q3 2024, ImageneBio's Liabilities and Shareholders Equity stood at $149.0 million, which was down 3081.11% from $157.5 million recorded in Q2 2024.
  • In the past 5 years, ImageneBio's Liabilities and Shareholders Equity ranged from a high of $293.7 million in Q1 2021 and a low of $149.0 million during Q3 2024
  • Over the past 5 years, ImageneBio's median Liabilities and Shareholders Equity value was $191.3 million (recorded in 2022), while the average stood at $203.9 million.
  • As far as peak fluctuations go, ImageneBio's Liabilities and Shareholders Equity surged by 4719.31% in 2021, and later crashed by 3308.32% in 2023.
  • Over the past 5 years, ImageneBio's Liabilities and Shareholders Equity (Quarter) stood at $168.4 million in 2020, then skyrocketed by 47.19% to $247.9 million in 2021, then plummeted by 30.51% to $172.3 million in 2022, then grew by 11.51% to $192.1 million in 2023, then decreased by 22.44% to $149.0 million in 2024.
  • Its Liabilities and Shareholders Equity stands at $149.0 million for Q3 2024, versus $157.5 million for Q2 2024 and $172.8 million for Q1 2024.